Jul 08, 2020 Share Share on Twitter Share on Facebook View this post on Instagram Co-founded by MIT biological engineers, Jacob Becraft, Strand Therapeutics is an early-stage biotechnology company that delivers revolutionary therapies for patients around the world through genetically programmed mRNA. ⠀⠀⠀⠀⠀⠀⠀⠀⠀ ➖Is COVID-19 reshaping public perception of the biopharmaceutical industry? The collectivism of the biotech community is inspiring. Media cycles have been tough on biotechs and the pharmaceutical industry. With this experience, we’re seeing up close just how important our community’s work is. When therapies are tucked away in corners of hospitals treating sick people, it’s not immediately obvious what we're doing or creating. ⠀⠀⠀⠀⠀⠀⠀⠀⠀ ➖How are your scientists doing right now? This community cares about patients and public health. Our scientists are doing all they can to help—and there’s a lot of excitement to do something. We all hope that what we’re working on is important. With a massive threat like COVID-19, the things we're making can be most impactful and that’s a fulfilling process. This is an amazing time to witness. #kendallcollective A post shared by Kendall Square Association (@ksq_association) on Jul 8, 2020 at 10:59am PDT